Literature DB >> 30446978

Steady Flow in a Patient-Averaged Inferior Vena Cava-Part II: Computational Fluid Dynamics Verification and Validation.

Brent A Craven1, Kenneth I Aycock2, Keefe B Manning3.   

Abstract

PURPOSE: The embolus trapping performance of inferior vena cava (IVC) filters critically depends on how emboli flow through the IVC and, thereby, on the underlying hemodynamics. Most previous studies of IVC hemodynamics have used computational fluid dynamics (CFD), but few have validated their results by comparing with quantitative experimental measurements of the flow field and none have validated in an anatomical model of the IVC that includes the primary morphological features that influence the hemodynamics (iliac veins, infrarenal curvature, and non-circular vessel cross-section). In this study, we perform verification and validation of CFD simulations in a patient-averaged anatomical model of the IVC.
METHODS: Because we are most interested in the fluid dynamics that influence embolus transport and IVC filter embolus trapping, we focus our analyses on the velocity distribution and the amount of swirl and mixing in the infrarenal IVC. A rigorous mesh refinement study is first conducted at the highest flow rate condition to verify the computed solutions. To validate the CFD predictions of the flow patterns, we then compare with particle image velocimetry (PIV) data acquired in the same model in two planes (coronal and sagittal) within the infrarenal IVC at two flow rates corresponding to rest and exercise conditions.
RESULTS: Using unstructured hexahedral meshes ranging in size from 800,000 to 102.5 million computational cells, we demonstrate that a coarse mesh may be used to resolve the gross flow patterns and velocity distribution in the IVC. A finer mesh is, however, required to obtain asymptotic mesh convergence of swirl and mixing in the IVC, as quantified by the local normalized helicity, LNH, and the volume-averaged helicity intensity, [Formula: see text]. Based on the results of the mesh refinement study, we use a moderately fine mesh containing approximately 26 million cells for comparison with experimental data. The validation study demonstrates excellent qualitative agreement between CFD predictions and PIV measurements of the velocity field at both conditions. Quantitatively, we show that the global relative comparison error, E, between CFD and PIV ranges from 3 to 11%. By performing sensitivity studies, we demonstrate that the quantitative discrepancy is attributable to a combination of uncertainty in the inlet flow rates and uncertainty associated with precisely aligning the PIV data with the CFD geometry.
CONCLUSIONS: Overall, the study demonstrates mesh-convergent CFD simulations that predict IVC flow patterns that agree reasonably well with PIV data, even at exercise conditions where the flow in the IVC is extremely complex.

Entities:  

Keywords:  Computational fluid dynamics; Hemodynamics; Inferior vena cava; Verification and validation

Mesh:

Year:  2018        PMID: 30446978     DOI: 10.1007/s13239-018-00392-0

Source DB:  PubMed          Journal:  Cardiovasc Eng Technol        ISSN: 1869-408X            Impact factor:   2.495


  4 in total

1.  An Immersed Interface Method for Discrete Surfaces.

Authors:  Ebrahim M Kolahdouz; Amneet Pal Singh Bhalla; Brent A Craven; Boyce E Griffith
Journal:  J Comput Phys       Date:  2019-07-29       Impact factor: 3.553

2.  Immersed Methods for Fluid-Structure Interaction.

Authors:  Boyce E Griffith; Neelesh A Patankar
Journal:  Annu Rev Fluid Mech       Date:  2019-09-05       Impact factor: 18.511

3.  A sharp interface Lagrangian-Eulerian method for rigid-body fluid-structure interaction.

Authors:  E M Kolahdouz; A P S Bhalla; L N Scotten; B A Craven; B E Griffith
Journal:  J Comput Phys       Date:  2021-05-18       Impact factor: 4.645

4.  Hemodynamic Analysis of VenaTech Convertible Vena Cava Filter Using Computational Fluid Dynamics.

Authors:  Jingying Wang; Wen Huang; Yue Zhou; Fangzhou Han; Dong Ke; Chunhian Lee
Journal:  Front Bioeng Biotechnol       Date:  2020-10-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.